Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Gabriel Leprivier
Affiliation
Institute of Neuropathology, Heinrich-Heine University Dusseldorf
ORCID
Career Start Year
2006
Papers
41
H Index
19
Expertise
CM4AI Collaborator
Antoine Forget (CM4AI)
PMID
Paper Title
Journal Title
Published Year
36639156
Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammation.
J Immunother Cancer
2023
37656187
Integrative multi-omics reveals two biologically distinct groups of pilocytic astrocytoma.
Acta Neuropathol
2023
37976029
The long non-coding RNA OTX2-AS1 promotes tumor growth and predicts response to BCL-2 inhibition in medulloblastoma.
J Neurooncol
2023
36443441
Elevated FSP1 protects KRAS-mutated cells from ferroptosis during tumor initiation.
Cell Death Differ
2023
35228525
Eukaryotic translation initiation factor 4E binding protein 1 (EIF4EBP1) expression in glioblastoma is driven by ETS1- and MYBL2-dependent transcriptional activation.
Cell Death Discov
2022
35379801
EIF4EBP1 is transcriptionally upregulated by MYCN and associates with poor prognosis in neuroblastoma.
Cell Death Discov
2022
35831316
The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumors.
Nat Commun
2022
34584066
The long non-coding RNA HOTAIRM1 promotes tumor aggressiveness and radiotherapy resistance in glioblastoma.
Cell Death Dis
2021
32351714
How does mTOR sense glucose starvation? AMPK is the usual suspect.
Cell Death Discov
2020
33371210
Rapalink-1 Targets Glioblastoma Stem Cells and Acts Synergistically with Tumor Treating Fields to Reduce Resistance against Temozolomide.
Cancers (Basel)
2020
33177490
4EBP1/2 are active under standard cell culture conditions to regulate the translation of specific mRNAs.
Cell Death Dis
2020
31081944
The long noncoding RNA TP73-AS1 promotes tumorigenicity of medulloblastoma cells.
Int J Cancer
2019
31993493
RAS-driven oncogenesis is supported by downstream antioxidant programs.
Mol Cell Oncol
2019
31852884
The impact of oncogenic RAS on redox balance and implications for cancer development.
Cell Death Dis
2019
30867410
The lncRNA TP73-AS1 is linked to aggressiveness in glioblastoma and promotes temozolomide resistance in glioblastoma cancer stem cells.
Cell Death Dis
2019
30704052
High-Throughput Screening Identified Compounds Sensitizing Tumor Cells to Glucose Starvation in Culture and VEGF Inhibitors In Vivo.
Cancers (Basel)
2019
31000598
Cystine/glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance.
Proc Natl Acad Sci U S A
2019
29348556
Puromycin labeling does not allow protein synthesis to be measured in energy-starved cells.
Cell Death Dis
2018
28574509
MYCN amplified neuroblastoma requires the mRNA translation regulator eEF2 kinase to adapt to nutrient deprivation.
Cell Death Differ
2017
28090356
Long noncoding RNA: noncoding and not coded.
Cell Death Discov
2017
28767324
eEF2K protects MYCN-amplified cells from starvation.
Cell Cycle
2017
28815059
Erratum: Long noncoding RNA: noncoding and not coded.
Cell Death Discov
2017
26829052
Eukaryotic initiation factor 4E-binding protein 1 (4E-BP1): a master regulator of mRNA translation involved in tumorigenesis.
Oncogene
2016
25464034
Stress-mediated translational control in cancer cells.
Biochim Biophys Acta
2015
25965573
Translational Activation of HIF1α by YB-1 Promotes Sarcoma Metastasis.
Cancer Cell
2015
25800057
YB-1 regulates stress granule formation and tumor progression by translationally activating G3BP1.
J Cell Biol
2015
24516159
HACE1 reduces oxidative stress and mutant Huntingtin toxicity by promoting the NRF2 response.
Proc Natl Acad Sci U S A
2014
25244326
How does oncogene transformation render tumor cells hypersensitive to nutrient deprivation?
Bioessays
2014
23706743
The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation.
Cell
2013
24342878
Anti-oxidative stress response genes: bioinformatic analysis of their expression and relevance in multiple cancers.
Oncotarget
2013
24280494
[Surviving nutrient deprivation by restraining translation elongation: biological function of the eEF2 kinase].
Med Sci (Paris)
2013
23798677
Mutation of the salt bridge-forming residues in the ETV6-SAM domain interface blocks ETV6-NTRK3-induced cellular transformation.
J Biol Chem
2013
21941369
The AMPK stress response pathway mediates anoikis resistance through inhibition of mTOR and suppression of protein synthesis.
Cell Death Differ
2012
22967496
Identification and quantification of newly synthesized proteins translationally regulated by YB-1 using a novel Click-SILAC approach.
J Proteomics
2012
22179574
7th Tuscany Retreat on Cancer Research: genetic profiling, resistance mechanism and novel treatment concepts in cancer.
Cell Death Differ
2012
21903344
A possible role for long non-coding RNA in modulating signaling pathways.
Med Hypotheses
2011
20001963
Caspase cleavage of Ets-1 p51 generates fragments with transcriptional dominant-negative function.
Biochem J
2010
19022222
Ets-1 binds cooperatively to the palindromic Ets-binding sites in the p53 promoter.
Biochem Biophys Res Commun
2009
19377509
Ets-1 p27: a novel Ets-1 isoform with dominant-negative effects on the transcriptional properties and the subcellular localization of Ets-1 p51.
Oncogene
2009
19465391
Ets-1 p51 and p42 isoforms differentially modulate Stromelysin-1 promoter according to induced DNA bend orientation.
Nucleic Acids Res
2009
16652151
Stromelysin-1 expression is activated in vivo by Ets-1 through palindromic head-to-head Ets binding sites present in the promoter.
Oncogene
2006
1 - 41 of 41
Column Actions
Search
Recommended Authors
Carolyn Jones
University of Cambridge
Career Start Year
2012
Number of shared co-authors
1
Min Gao
College of Horticulture, China Agricultural University
Career Start Year
2012
Number of shared co-authors
0
Richard Mitter
The Francis Crick Institute
Career Start Year
2008
Number of shared co-authors
0
Johannes Haybaeck
Institute of Pathology, Medical University of Innsbruck
Career Start Year
2007
Number of shared co-authors
0
Silvano Piazza
International Centre for Genetic Engineering and Biotechnology
Career Start Year
2004
Number of shared co-authors
0
Nicholas A Graham
University of Southern California
Career Start Year
2004
Number of shared co-authors
1
Anupama E Gururaj
National Institute of Allergy and Infectious Disease, National Institutes of Health
Career Start Year
2002
Number of shared co-authors
0
Ivan Topisirovic
McGill University
Career Start Year
2001
Number of shared co-authors
2
Jan Koster
Amsterdam University Medical Centers location AMC
Career Start Year
1999
Number of shared co-authors
21
Agnieszka Bronisz
Mossakowski Medical Research Institute, Polish Academy of Sciences
Career Start Year
1999
Number of shared co-authors
0
John Le Quesne
Beatson Cancer Research Institute, University of Glasgow
Career Start Year
1998
Number of shared co-authors
0
John D Gordan
Quantitative Biosciences Institute (QBI), University of California San Francisco
Career Start Year
1996
Number of shared co-authors
0
Jason D Weber
Washington University School of Medicine
Career Start Year
1996
Number of shared co-authors
0
Davide Ruggero
University of California San Francisco
Career Start Year
1996
Number of shared co-authors
0
Paul S Mischel
Stanford University
Career Start Year
1994
Number of shared co-authors
4
Michael A White
University of Georgia
Career Start Year
1994
Number of shared co-authors
0
Andrei Goga
University of California San Francisco
Career Start Year
1993
Number of shared co-authors
0
Mircea Ivan
Indiana University School of Medicine
Career Start Year
1993
Number of shared co-authors
0
John Easton
St Jude Children's Research Hospital
Career Start Year
1991
Number of shared co-authors
9
E Alejandro Sweet-Cordero
University of California San Francisco
Career Start Year
1989
Number of shared co-authors
5
Dirk Geerts
Amsterdam University Medical Center
Career Start Year
1989
Number of shared co-authors
1
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year
1988
Number of shared co-authors
1
Kun-Liang Guan
University of California San Diego
Career Start Year
1988
Number of shared co-authors
4
Patrick Kwok-Shing Ng
The University of Texas MD Anderson Cancer Center
Career Start Year
1987
Number of shared co-authors
0
William C Hahn
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Career Start Year
1987
Number of shared co-authors
4
Rakesh Kumar
Rutgers New Jersey Medical School
Career Start Year
1987
Number of shared co-authors
2
Andrew D Cherniack
Dana-Farber Cancer Institute
Career Start Year
1984
Number of shared co-authors
2
Ze'ev Ronai
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Career Start Year
1981
Number of shared co-authors
1
Francisca Vazquez
Broad Institute of MIT and Harvard
Career Start Year
1979
Number of shared co-authors
2
Chi V Dang
Johns Hopkins University School of Medicine
Career Start Year
1978
Number of shared co-authors
1
row(s) 1 - 30 of 30
Collaborators
Barak Rotblat
Ben-Gurion University of the Negev
Co-authored papers
20
Poul H Sorensen
British Columbia Cancer Research Centre
Co-authored papers
15
Marc Remke
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Co-authored papers
11
Guido Reifenberger
Heinrich Heine University
Co-authored papers
10
Daniel Picard
Groupe Hospitalier Universitaire Pitie-Salpetriere
Co-authored papers
8
Nan Qin
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Co-authored papers
6
Thomas G P Gr??newald
German Cancer Research Center
Co-authored papers
6
Anja Stefanski
Universitatsklinikum
Co-authored papers
5
Arndt Borkhardt
Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf
Co-authored papers
5
David Pauck
German Cancer Research Center (DKFZ)
Co-authored papers
4
Jasmin Bartl
German Cancer Research Center (DKFZ)
Co-authored papers
4
Kai St??hler
Universitatsklinikum
Co-authored papers
4
Ute Fischer
Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf
Co-authored papers
4
Frauke-Dorothee Meyer
German Cancer Research Center (DKFZ)
Co-authored papers
4
Olivier Delattre
PSL Research University, Institut Curie Research Center, INSERM U, Institut Curie
Co-authored papers
4
Cristina E Tognon
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers
3
Viktoria Marquardt
German Cancer Research Center (DKFZ)
Co-authored papers
3
Alberto Delaidelli
Co-authored papers
3
Gian Luca Negri
British Columbia Cancer Research Institute
Co-authored papers
3
Martin E Gleave
University of British Columbia
Co-authored papers
3
Lena Bl??mel
German Cancer Research Center (DKFZ)
Co-authored papers
3
Yuzhuo Wang
University of British Columbia
Co-authored papers
2
Marietta Wolter
Institute of Neuropathology, Heinrich Heine University
Co-authored papers
2
Michael D Taylor
The Hospital for Sick Children
Co-authored papers
2
Paul A Northcott
St Jude Children's Research Hospital
Co-authored papers
2
Thomas Beez
Heinrich-Heine University Dusseldorf
Co-authored papers
2
Stefan M Pfister
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
2
Marcel Kool
Hopp Children's Cancer Center (KiTZ)
Co-authored papers
2
Till Milde
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
2
Michael Weller
University Hospital and University of Zurich
Co-authored papers
1
1 - 30